Marijuana Smoking and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium

Julien BERTHILLER; Yuan-Chin Amy LEE; CHU CHU CHEN; Stephen M SCHWARTZ; José ELUF NETO; Victor WÜNSCH FILHO; Sergio KOIFMAN; Maria Paula CURADO; Elena MATOS; Leticia FEMANDEZ; Ana MENEZES; Alexander W DAUDT; Paolo BOFFETTA; Gilles FERRO; Paul BRENNAN; Mia HASHIBE; QINGYI QINGYI WEI; Erich M STURGIS; Sander GREENLAND; Hal MORGENSTERN; Zuo-Feng ZHANG; Philip LAZARUS; Joshua MUSCAT

doi:10.1158/1055-9965.EPI-08-0845

Back

Marijuana Smoking and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium

Accepted manuscript

Open access

Peer reviewed

Marijuana Smoking and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium

Julien BERTHILLER, Yuan-Chin Amy LEE, CHU CHU CHEN, Stephen M SCHWARTZ, José ELUF NETO, Victor WÜNSCH FILHO, Sergio KOIFMAN, Maria Paula CURADO, Elena MATOS, Leticia FEMANDEZ, …

Cancer epidemiology, biomarkers & prevention, Vol.18(5), pp.1544-1551

2009

DOI: https://doi.org/10.1158/1055-9965.EPI-08-0845

Handle:

https://hdl.handle.net/2376/109926

PMCID: PMC3046921

PMID: 19423532

Files and links (2)

pdf

nihms270553505.12 kBDownload View

Open Access

url

https://doi.org/10.1158/1055-9965.EPI-08-0845View

Published (Version of record) Open

Abstract

Biological and medical sciences

Medical sciences

Tobacco, tobacco smoking

Toxicology

Tumors

Background—Marijuana contains carcinogens similar to tobacco smoke and has been suggested by relatively small studies to increase the risk of head and neck cancer (HNC). Since tobacco is a major risk factor for HNC, large studies with substantial numbers of never tobacco users could help to clarify whether marijuana smoking is independently associated with HNC risk.

Metrics

19 Record Views

See more details

Details

Title: Marijuana Smoking and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium
Creators: Julien BERTHILLER - IARC, Lyon, France
Yuan-Chin Amy LEE - IARC, Lyon, France
CHU CHU CHEN - Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Stephen M SCHWARTZ - Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
José ELUF NETO - Universidade de Sao Paulo, Sao Paulo, Brazil
Victor WÜNSCH FILHO - Universidade de Sao Paulo, Sao Paulo, Brazil
Sergio KOIFMAN - Escola Nacional de Saude Publica, Rio de Janeiro, Brazil
Maria Paula CURADO - IARC, Lyon, France
Elena MATOS - Institute of Oncology Angel H. Roffo, University of Buenos Aires, Buenos Aires, Argentina
Leticia FEMANDEZ - Institute of Oncology and Radiobiology, La Havana, Cuba
Ana MENEZES - Universidade Federal de Pelotas, Pelotas, Brazil
Alexander W DAUDT - Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
Paolo BOFFETTA - IARC, Lyon, France
Gilles FERRO - IARC, Lyon, France
Paul BRENNAN - IARC, Lyon, France
Mia HASHIBE - IARC, Lyon, France
QINGYI QINGYI WEI - University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Erich M STURGIS - University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Sander GREENLAND - Department of Epidemiology, University of California, Los Angeles School of Public Health, United States
Hal MORGENSTERN - Departments of Epidemiology and Environmental Health Sciences, School of Public Health, and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States
Zuo-Feng ZHANG - Department of Epidemiology, University of California, Los Angeles School of Public Health, United States
Philip LAZARUS - Penn State College of Medicine, Hershey, Pennsylvania, United States
Joshua MUSCAT - Penn State College of Medicine, Hershey, Pennsylvania, United States
Publication Details: Cancer epidemiology, biomarkers & prevention, Vol.18(5), pp.1544-1551
Academic Unit: Department of Pharmaceutical Sciences
Publisher: American Association for Cancer Research; Philadelphia, PA
Number of pages: 8
Identifiers: 99900547125201842
Language: English
Resource Type: Accepted manuscript